Tom Ford

Conjoint Associate Professor Tom Ford is an Interventional Cardiologist at the University of Newcastle's School of Medicine and Public Health. He serves as director of Central Heart on the Central Coast of NSW and holds appointments as the Australian National Young Ambassador to EAPCI (European Association for Percutaneous Coronary Intervention). He is also a Fellow of the Royal College of Physicians (Edinburgh) and Fellow of Cardiac Society for Australia/New Zealand (FCSANZ).

Dr. Ford completed his medical training at the University of Dundee, receiving the University Medal (Captain WA Low Prize 2007). He gained the MRCP at the Royal College of Physicians in Edinburgh before emigrating to Australia in 2010. He completed his FRACP during advanced cardiology training at Prince of Wales Hospital and St George Hospital in Sydney. His subspecialty training included a three-year fellowship at Glasgow's Golden Jubilee National Hospital, the UK's highest volume center for coronary stents, where he also completed his PhD which won the prestigious Bellahouston Medal.

Dr. Ford's research focuses on coronary physiology, interventional cardiology, and microvascular angina, with particular expertise in angina and ischemic heart disease. His work bridges clinical practice and research, investigating coronary vasomotor disorders, complex percutaneous coronary interventions, and chronic total occlusions. His recent publications demonstrate a strong emphasis on functional coronary angiography, coronary microvascular dysfunction assessment techniques, and the development of targeted therapies for microvascular disease.

Dr. Ford has received significant recognition for his work including the Bellahouston Medal for his PhD thesis, EuroPCR Best Abstract award, and the British Cardiac Society's 'Best of the Best' Clinical Abstract award in Interventional Cardiology. His research has been published in leading cardiology journals and he has been invited faculty at major cardiology scientific sessions including the American Heart Association, European Society of Cardiology, EuroPCR, and Transcatheter Cardiovascular Therapeutics.

Dr. Ford actively participates in multicenter clinical trials and registries including the CorMicA trial, TARGET-FFR study, and the Australian-New Zealand Spontaneous Coronary Artery Dissection (ANZ-SCAD) Registry. His clinical practice combines advanced interventional techniques with a focus on diagnosing and managing patients with complex coronary conditions, particularly those with angina but without obstructive coronary artery disease.